Synapse - Find an Expert

33620 Results

Disparities in speed to BMT consult and allograft in 279 adults with AML

Meeting Abstract

Fingrut, W. B.; Gyurkocza, B.; Davis, E.; Flynn, J.; Scaradavou, A.; Chinapen, S.; Naputo, K.; Quach, S.; Cho, C.; Giralt, S.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Time to response, duration of response, and patient-reported outcomes (PROs) with daratumumab (DARA) plus lenalidomide and dexamethasone (D-Rd) versus lenalidomide and dexamethasone (Rd) alone in transplant-ineligible patients with newly diagnosed multiple myeloma (NDMM): Subgroup analysis of the phase 3 MAIA study

Meeting Abstract

Facon, T.; Kumar, S.; Plesner, T.; Moreau, P.; Bahlis, N. J.; Goldschmidt, H.; O'Dwyer, M.; Perrot, A.; Christopher; Venner, P.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Subcutaneous epcoritamab with rituximab + lenalidomide (R(2)) in patients (pts) with relapsed or refractory (R/R) follicular lymphoma (FL): Update from phase 1/2 trial

Meeting Abstract

Falchi, L.; Leppä, S.; Wahlin, B. E.; Nijland, M.; Christensen, J. H.; De Vos, S.; Holte, H.; Linton, K. M.; Abbas, A.; Wang, L.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Automated assessment of illness and treatment understanding (ITU) via the Memorial Sloan Kettering Patient Portal

Meeting Abstract

Epstein, A. S.; Bernal, C.; Romano, D. R.; Goldberg, J.; Desai, A. V.; Nelson, J. E.
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Next-generation sequencing (NGS) of circulating cell-free DNA (cfDNA) in patients (pts) with advanced hepatocellular carcinoma (HCC)

Meeting Abstract

Cowzer, D.; White, J. B.; Chen, P. J.; Kim, T. H.; Khalil, D.; El Dika, I. H.; Chou, J. F.; Yaqubie, A.; Light, J. S.; Shia, J.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

First-line treatment (Tx) with subcutaneous (SC) epcoritamab (epco) + R-CHOP in patients (pts) with high-risk diffuse large B-cell lymphoma (DLBCL): Phase 1/2 data update

Meeting Abstract

Falchi, L.; Offner, F.; Belada, D.; Brody, J.; Linton, K. M.; Karimi, Y.; Cordoba, R.; Snauwaert, S.; Abbas, A.; Wang, L.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

First-in-human study of PC14586, a small molecule structural corrector of Y220C mutant p53, in patients with advanced solid tumors harboring a TP53 Y220C mutation

Meeting Abstract

Dumbrava, E. E.; Johnson, M. L.; Tolcher, A. W.; Shapiro, G.; Thompson, J. A.; El-Khoueiry, A. B.; Vandross, A. L.; Kummar, S.; Parikh, A. R.; Munster, P. N.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Randomized phase II study of platinum and etoposide (EP) versus temozolomide and capecitabine (CAPTEM) in patients (pts) with advanced G3 non-small cell gastroenteropancreatic neuroendocrine neoplasms (GEPNENs): ECOG-ACRIN EA2142

Meeting Abstract

Eads, J. R.; Catalano, P. J.; Fisher, G. A.; Rubin, D.; Iagaru, A.; Klimstra, D. S.; Konda, B.; Kwong, M. S.; Chan, J. A.; De Jesus-Acosta, A.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

A pilot study of neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab in patients with resectable, locally advanced head and neck squamous cell carcinoma (HNSCC)